OTC Markets OTCPK - Delayed Quote USD
Kadimastem Ltd (KMSTF)
5.06
0.00
(0.00%)
At close: June 5 at 8:00:00 PM EDT
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Ronen Twito CPA | CEO & Executive Chairman | 421k | -- | 1975 |
| Mr. Uri Ben-Or | Chief Financial Officer | 265k | -- | 1970 |
| Prof. Michel Revel M.D., Ph.D. | Co-Founder, Chief Scientist, Head of the Scientific Advisory Board & Director | 480k | -- | 1938 |
| Mr. Yossi Ben-Yossef | Honorary President & Strategic Consultant | 1.14M | -- | 1957 |
| Mr. Olivier Samuel | VP of European Business Development & Director | 146k | -- | 1974 |
Kadimastem Ltd
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 11
Description
Kadimastem Ltd, a biopharmaceutical company, develops regenerative medicine therapies based on cells derived from human embryonic stem cells to treat neuro-degenerative diseases. Its products in pipeline include AstroRx, a clinical grade human astrocytes that is in Phase 1/2a clinical trial for the treatment of amyotrophic lateral sclerosis and other neurodegenerative diseases; and IsletRx, a clinical grade pancreatic islet cell therapy treatment for diabetes. The company was incorporated in 2008 and is based in Ness Ziona, Israel.
Corporate Governance
Kadimastem Ltd’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
NLSPW NLS Pharmaceutics AG
0.0184
-14.02%
NTRBW Nutriband Inc.
2.2300
0.00%
ELDN Eledon Pharmaceuticals, Inc.
3.0800
+3.36%
INDP Indaptus Therapeutics, Inc.
0.3433
-1.04%
GLTO Galecto, Inc.
3.2900
+0.61%
AMPE Ampio Pharmaceuticals, Inc.
0.1305
0.00%
NLSP NLS Pharmaceutics AG
2.3000
+10.58%
SWTX SpringWorks Therapeutics, Inc.
46.80
0.00%
NRXS NeurAxis, Inc.
2.6100
+0.38%
RZLT Rezolute, Inc.
4.4300
+2.78%